Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05417568 · ClinicalTrials.gov registry record · NA
Oxalate-Driven Host Responses in Kidney Stone Disease
A NA study of Kidney Stones, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT05417568: Recruiting NA study of Kidney Stones, sponsored by University of Alabama at Birmingham.
NCT05417568 is a NA study of Kidney Stones that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 88 participants, below the 289-participant average among 15 other Kidney Stones trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05417568, a NA study of Kidney Stones, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is looking to understand the role of oxalate on kidney stone development and immunity. This study will enroll healthy participants and participants with calcium oxalate kidney stones (CaOx KS). Participants will be in this study for about 3 weeks, consume controlled diets, and provide blood and urine specimens.
Primary Outcome
Twenty-four hour urinary oxalate will be reported as mg/day.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Low Oxalate Diet
- DIETARY_SUPPLEMENT High Oxalate Diet
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2023-05-19 |
| Est. Completion | 2027-05-30 |
| Phase | NA |
What NCT05417568 shows while recruiting
NCT05417568 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 289-participant average among 15 other Kidney Stones trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which Low Oxalate Diet is the first listed.
NCT05417568 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05417568 about?
NCT05417568 is a clinical study titled "Oxalate-Driven Host Responses in Kidney Stone Disease". This study is looking to understand the role of oxalate on kidney stone development and immunity. This study will enroll healthy participants and participants with calcium oxalate kidney stones (CaOx KS). Participants will be in this study for about 3 weeks, consume controlled diets, and provide blo...
What is the current status of trial NCT05417568?
This trial is currently recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2023-05-19. Estimated completion is 2027-05-30.
What conditions does trial NCT05417568 study?
This clinical trial studies the following conditions: Kidney Stones.
What interventions are being tested in trial NCT05417568?
The interventions under investigation include: Low Oxalate Diet (DIETARY_SUPPLEMENT), High Oxalate Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05417568?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05417568 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stones
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05417568's enrollment target sits among peer trials
88 5th of 15 higher than 11 of 15 other Kidney Stones trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stones trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Evaluation of Eye Gaze Sharing in the Operating Room
RECRUITING · NA
-
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
RECRUITING · NA
-
Eye Gaze Guidance Evaluation in Phantoms
RECRUITING · NA
-
Ultrasound Imaging of Kidney Stones and Lithotripsy
ACTIVE NOT RECRUITING · NA
-
Effect of Diet Orange Soda on Urinary Lithogenicity
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI